SHINE Medical Technologies plans to use fissioning of a low enriched uranium (LEU) solution as uranyl sulfate for molybdenum-99 production. One of the major concerns for SHINE is peroxide formation from radiolysis, which can lead to precipitation of uranyl peroxide. Bench-top experiments where peroxide was added directly to a uranyl sulfate solution were performed to determine the concentration where precipitation occurs as a function of temperature and concentration of ferrous or ferric ion to aid in peroxide destruction. Based on the experimental results and relevant literature, a thermodynamic/kinetic model for the precipitation of uranyl peroxide for a given set of conditions was developed and tested. The conditions that must be specified in the model are temperature, uranyl sulfate concentration, ferrous-or ferric-ion concentration, and the H 2 O 2 production rate. Additionally, experiments were performed using the Van de Graaff accelerator as a radiation source for radiolytically induced peroxide formation. Uranyl peroxide precipitated at 12°C when a uranyl sulfate solution was exposed to a radiation dose of 7900 Mrad in the pulse mode, but precipitation did not occur in the direct current (DC) mode at much higher powers. Because precipitation could not be achieved in the DC mode for this set of experiments, the effects of temperature and power on uranyl peroxide formation could not be determined. Future experiments will monitor current continuously, measure gas flow rates continuously, and use a uranyl sulfate solution that contains little to no iron impurity.